Higher prevalence of oral HPV in men than women, and peaks at ages 30 to 34 years and 60 to 64 years correlate with trends in oropharyngeal squamous-cell carcinoma incidence.
HPV Information Center
Clinicians must consider patient sexual history in the decision-making process for adult HPV vaccination.
The cobas HPV test detects DNA from 14 types of HPV and included types 16 and 18, which cause 70% of cervical cancers.
DNA testing for human papillomavirus (HPV) picks up precancerous lesions earlier and prevents more cervical cancer than standard cytology screening alone.
Efforts to improve HPV vaccine uptake in boys should focus on parent education, link between virus and cancer.
The potential costs and effectiveness of HPV4 vaccination versus no vaccination were compared in a theoretical cohort based on a cohort of 192,940 boys aged 12 years.
AANP 2011 Conference
Clinician-patient education programs can help dispel human papillomavirus vaccine misconceptions and improve uptake rates, according to a researcher at the American Academy of Nurse Practitioners 26th Annual NP meeting.
Female clinicians twice as likely to order HPV testing for any cytology results in low-risk women.
DNA-based testing for HPV-16 and HPV-18 detects cervical cancer better than liquid-based cytology, data from the ATHENA trial indicate.
Offers a concise, practical summary of the research findings reported in Paavonen J, Naud P, Salmerón J, et al; the HPV PATRICIA study group. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301-314.